Bishal Gyawali, Associate Professor at Queen’s University, shared a post on LinkedIn:
“I hope you take some time to read our deliberations and discussions at the WHO EML cancer drugs working group meeting re checkpoint inhibitors in treating solid cancers.”
More posts featuring Bishal Gyawali.